Skip to main content
Press Releases

AlaskOmega Participates in a Landmark Publication on Omega-7

By February 26, 2018October 2nd, 2019No Comments

AlaskOmega Participates in a Landmark Publication on Omega-7

Coshocton, OH – February 26, 2018. AlaskOmega announces the publication of the first comprehensive review of the effects of palmitoleic acid by Molecular Nutrition & Food Research. Palmitoleic acid, an omega-7 fatty acid, has been proposed as a plausible alternative to prevent, control, or ameliorate chronic metabolic and inflammatory disorders.

Palmitoleic acid is a monounsaturated fatty acid that can be synthesized in humans and obtained directly from macadamia nut, sea buckthorn, and some fish oils. It circulates in the blood along with other fatty acids and is a component of cell membranes. The recently published review is a significant advancement in the field of dietary fatty acid research, as it summarizes the immune and metabolic effects of palmitoleic acid from over 40 studies.

“While the human data are inconsistent and clinical work is needed, the research in cell culture and animals shows many positive effects of palmitoleic acid”, remarked Gretchen Vannice, MS, RDN, Head of Global Nutrition Education at AlaskOmega and co-author of the review, together with Camila Souza, PhD and Philip Calder, PhD, University of São Paulo and University of Southampton, respectively. “This little known fatty acid is intriguing,” continued Vannice, “having been shown to improve insulin function and reduce inflammation and fatty liver in animals. We are excited to contribute to the body of research on palmitoleic acid.”

“There is actually quite a lot of literature on palmitoleic acid” added Philip Calder, a world-renowned expert in fatty acid research, “but strong human evidence for its benefits is currently lacking. However, given its potential roles in health I think that more human research should be done.”

Publication: Souza, C.O., Vannice, G.K., Rosa Neto, J.C., & Calder, P.C.; Is palmitoleic acid a plausible non-pharmacological strategy to prevent or control chronic metabolic and inflammatory disorders? Molecular Nutrition & Food Research; January, 2018 (online).

About AlaskOmega®
Organic Technologies is the producer of MSC-certified AlaskOmega® fish oil products, including omega-3 concentrates, natural fish oils, and omega-7 concentrates sourced from wild-caught Alaska Pollock from Alaska’s Bering Sea. AlaskOmega® omega-3 concentrates are available up to 85% total Omega-3 content in EE/TG form, and omega-7 available in 50% and 70% concentrations. Please visit for more information.
AlaskOmega Media Contact: Steve Dillingham /